Nov 20: University Innovation Symposium

UAEM University Innovation Symposium

November 20, 2010 from 8:30 A.M. until 6:30 P.M.

Symposium Location: 

American University, Washington College of Law, Room 603
4801 Massachusetts Ave., NW Washington, DC 20016

PIJIP and Universities Allied for Essential Medicines cohosted this symposium for NGO representatives, university professors and administrators, and policy makers focused on strategies to increase research on neglected diseases and innovative policies for universities to contribute most effectively to the medicines innovation system. Topics included intellectual property protection, licensing, and alternate models of funding.

Links:

 

Universities are increasingly integrated into the pharmaceutical innovation system. Institutions such as Yale and the University of British Columbia, for instance, now have their own high through-put screening facilities, traditionally controlled only by industry, which allow them to do rapid tests of thousands of molecules in their compound libraries to screen for potential new drug targets.  Yale has taken this a step further by purchasing a facility from pharmaceutical company Bayer in order to quicken the pace and scope of its biomedical research capabilities. 

Universities are also engaging increasingly with product development partnerships product development partnerships (PDPs) such as DNDi to aid them in finding cures for diseases of the poor.  Combined with the trend toward open access publishing standards for academic papers at many schools, universities are well placed to accelerate the ability of researchers to find life-saving discoveries. 

In order to address and further explore these possibilities, UAEM is holding a symposium on the role of universities as non-profit institutions in the medicine innovation system, particularly related to their role in finding cures for neglected diseases as well as open-source research methods. 

The meeting will bring together product development partnerships (PDPs), university administrators, researchers, industry actors, technology transfer officials, funding institutions and students to explore the role of universities in the broader innovation system and directions for university policy to best improve both innovation and access to medicines. 

We hope you can join us as we gather in Washington, D.C., on November 20, 2010 from 8:30 A.M to 6:30 P.M.

Please continue to check back at this site for the most updated information regarding the conference. We look forward to seeing you in November.

The symposium is made possible by the kind support of the Perls Foundation

Speakers and Participants

  • Rohit Malpani, Oxfam
  • Bhaven Sampat, Columbia University 
  • Gloria Tavera, NIH Research Fellow, UAEM
  • Kishor Wasan, University of British Columbia
  • Rita Khanna, Aeras Global TB Vaccine Foudation
  • Sandeep Kishore, Weill-Cornell Medical College, UAEM
  • James Love, Director, Knowledge Ecology International
  • Paul Wilson, Assistant Professor of Clinical Population and Family Health , Columbia University
  • Pamela Small, University of Tennessee
  • Zakir Thomas, Open Source Drug Discovery Network, India
  • Heather Joseph, Executive Director, SPARC
  • Rebecca Goulding, Open Health Initiative 
  • Matt Todd, The Synaptic Leap, Australia
  • Dr. Tom Wellems, National Institute of Allergy and Infectious Disease
  • Rachel Kiddell-Monroe, Universities Allied for Essential Medicines

 

 


Photo of pills (cc) Fillmore Photography.